Intrauterine growth restriction

Current Opinion in Obstetrics and Gynecology

Volumn 14, Issue 2, 2002, Pages 127-135

  Maršál, Karel ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADRENOMEDULLIN; GLUTAREDOXIN; HOMOCYSTEINE; LEPTIN; NITRIC OXIDE; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THIOREDOXIN;

CENTRAL NERVOUS SYSTEM; EARLY DIAGNOSIS; FETUS CIRCULATION; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS HEART RATE; FETUS HYPOXIA; FETUS WEIGHT; GESTATIONAL AGE; HEART RATE VARIABILITY; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; UMBILICAL ARTERY;

BLOOD FLOW VELOCITY; FEMALE; FETAL GROWTH RETARDATION; FETAL WEIGHT; GESTATIONAL AGE; GROWTH SUBSTANCES; HOMOCYSTEINE; HUMANS; INFLAMMATION; PLACENTAL CIRCULATION; PREGNANCY; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UMBILICAL ARTERIES;

EID: 0036215458     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200204000-00005     Document Type: Review

References (61)

1. Folio acid and homocysteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review
2. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction
3. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction
4. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction
5. Disturbed feto-maternal cell traffic in preeclampsia
6. Fetal hemoglobin-expressing nucleated red blood cell frequencies in pregnancies with intrauterine growth restriction
7. Maternal insulin-like growth factor binding protein 1, body mass index, and fetal growth
8. Intrauterine growth restriction without pre-eclampsia and associated changes in serum inhibin A and activin A levels: A case report
9. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3 and the soluble IGF-II/mannose-6-phosphate receptor in term human infants
10. The relationship of the levels of leptin, insulin-like growth factor-1 and insulin in cord blood with birth size, ponderal index, and gender difference
11. Cord leptin level and fetal macrosomia
12. Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms
13. Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia
14. Expression of insulin-like growth factor-1 and placental growth hormone mRNA in placentae: A comparison between normal and intrauterine growth retardation pregnancies
15. Hypothesis of functional inadequacy of thioredoxin and related systems in preeclampsia
16. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction
17. Circulating thyroid hormones and placental TR isoform expression in IUGR
18. Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction
19. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
20. The relationship between intrauterine growth restriction and preterm delivery: An empirical approach using data from a European case-control study
21. Does a discrepancy between gestational age determined by biparietal diameter and last menstrual period sometimes signify early intrauterine growth retardation?
22. Sonographic estimation of fetal weight based on a model of fetal volume
23. Fetal weight estimation by three-dimensional ultrasound
24. Prenatal detection of a high-risk group for intrauterine growth restriction based on sonographic fetal biometry
25. Antenatal detection of intrauterine growth restriction in patients with systemic lupus erythematosus
26. Abdominal circumference: A single measurement versus growth rate in the prediction of intrapartum Cesarean section for fetal distress
27. Conditional centiles for the quantification of fetal growth
28. Using unconditional and conditional standard deviation scores of fetal abdominal area measurements in the prediction of intrauterine growth restriction
29. Relationship between the sonographic pattern of intrauterine growth restriction and acid-base status at the time of cordocentesis
30. Antenatal assessment of the growth restricted fetus
31. Intrauterine growth restriction and Doppler ultrasonography
32. Abnormal fetal cerebral and umbilical Doppler measurements in fetuses with intrauterine growth restriction predicts the severity of perinatal morbidity
33. Doppler assessment of umbilical artery, thoracic aorta and middle cerebral artery in the management of pregnancies with growth restriction
34. A critical appraisal of the use of umbilical artery Doppler ultrasound in high risk pregnancies: Use of meta-analyses in evidence-based obstetrics
35. Middle cerebral artery Doppler in severe intrauterine growth restriction
36. Fetal adrenal and middle cerebral artery Doppler velocimetry in high-risk pregnancy
37. Fetal adrenal artery velocimetry measurements in appropriate-for-gestational age and intrauterine growth-restricted fetuses
38. Demonstration of fetal coronary blood flow by Doppler ultrasound in relation to arterial and venous flow velocity waveforms and perinatal outcome - The 'heart sparing effect'
39. Coronary artery blood flow visualization signifies hemodynamic deterioration in growth-restricted fetuses
40. Renal artery flow-velocity waveforms in normal and hypoxemic fetuses
41. Normal values of pulsatility index from fetal vessels: A cross-sectional study on 1556 healthy fetuses
42. Doppler studies on the fetal renal artery in the severely growth-restricted fetus
43. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction
44. Longitudinal changes in the ductus venosus, cerebral transverse sinus and cardiotocogram in fetal growth restriction
45. Umbilical vein blood flow in growth-restricted fetuses
46. Fetal umbilical flow measured in utero by pulsed Doppler mode and B-mode ultrasound
47. Fetal blood flow in pregnancies complicated by intrauterine growth retardation
48. Abnormal fetal aortic velocity waveform and minor neurological dysfunction at 7 years of age
49. Abnormal fetal aortic velocity waveform and intellectual function at 7 years of age
50. Monitoring of fetuses with intrauterine growth restriction: A longitudinal study
51. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens
52. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease
53. Ventriculovascular physiology of the growth-restricted fetus
54. Doppler investigation of uteroplacental blood flow in the second trimester: A screening study for pre-eclampsia and intrauterine growth retardation
55. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation
56. Uterine artery Doppler: Time to establish the ground rules
57. Quantification of the diastolic notch in Doppler ultrasound screening of uterine arteries
58. Predicting the risk of pre-eclampsia and a small-for-gestational age infant by quantitative assessment of the diastolic notch in uterine artery flow velocity waveforms in unselected women
59. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation
60. Uterine artery Doppler and placental volume in the first trimester in the prediction of pregnancy complications
61. Reproducibility and repeatability of transabdominal uterine artery Doppler velocimetry between 10 and 14 weeks of gestation